Cardiac Biotech Solutions, Inc. (CBSC)
0.035
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Cardiac Biotech Solutions Net Income (Quarterly) : -0.1372M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1372M |
| March 31, 2026 | -0.103M |
| December 31, 2025 | -0.5737M |
| September 30, 2025 | -0.0405M |
| June 30, 2025 | -0.1907M |
| March 31, 2025 | -0.3985M |
| December 31, 2024 | -0.6759M |
| September 30, 2024 | -0.3419M |
| June 30, 2024 | -0.2644M |
| March 31, 2024 | -0.3319M |
| December 31, 2023 | -0.487M |
| September 30, 2023 | -0.4912M |
| June 30, 2023 | -0.3201M |
| March 31, 2023 | -0.7633M |
| December 31, 2022 | -0.4292M |
| September 30, 2022 | -0.4486M |
| June 30, 2022 | -0.4655M |
| March 31, 2022 | -1.474M |
| December 31, 2021 | -4.003M |
| September 30, 2021 | -0.3929M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.4719M |
| March 31, 2021 | -2.059M |
| December 31, 2020 | -0.5582M |
| September 30, 2020 | -1.702M |
| June 30, 2020 | -0.167M |
| March 31, 2020 | -0.0175M |
| December 31, 2019 | |
| June 30, 2019 | -0.0174M |
| March 31, 2019 | 0.1801M |
| December 31, 2018 | -0.0266M |
| September 30, 2018 | -0.1109M |
| June 30, 2018 | -0.1052M |
| March 31, 2018 | -0.3979M |
| December 31, 2017 | -0.5054M |
| September 30, 2017 | -0.1017M |
| June 30, 2017 | -0.1265M |
| March 31, 2017 | -0.1074M |
| December 31, 2016 | -0.0532M |
| September 30, 2016 | -0.1446M |
| June 30, 2016 | -0.0475M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Vyome Holdings, Inc. | -0.7197M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0402M |
| Total Expenses (Quarterly) | 0.1773M |
| EPS Diluted (Quarterly) | -0.0008 |
| Enterprise Value | 6.491M |
| Profit Margin (Quarterly) | -341.3% |
| Earnings Yield | -14.57% |
| Normalized Earnings Yield | -19.71 |